newsfilter
← Latest News
PR Newswire·

Update on U.S. FDA Review of Biologics License Application (BLA) for bimekizumab

BRUSSELS and ATLANTA, Oct. 16, 2021 /PRNewswire/ -- Regulated Information – Inside Information – UCB, a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that they were unable